Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Previously Treated Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03014648
What this trial is testing

Evaluating the Efficacy of Atezolizumab in Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Advanced Non-small Cell Lung Cancer
Liza Villaruz, MD 28
Testing effectiveness (Phase 2)WithdrawnNCT00697060
What this trial is testing

A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AmpliMed Corporation
Testing effectiveness (Phase 2)Study completedNCT00673569
What this trial is testing

Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 40
Large-scale testing (Phase 3)UnknownNCT01066195
What this trial is testing

Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 129
Testing effectiveness (Phase 2)Study completedNCT06029127
What this trial is testing

Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 35
Large-scale testing (Phase 3)Study completedNCT01999673
What this trial is testing

Phase 3 Study of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Late-stage Non-squamous Non-small-cell Lung Cancer

Who this might be right for
Non-Small-Cell Lung Cancer Stage IIIBNon-Small-Cell Lung Cancer Stage IVNon-Small-Cell Lung Cancer Metastatic+4 more
Peregrine Pharmaceuticals 582
Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Early research (Phase 1)Study completedNCT01466647
What this trial is testing

The IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Axelar AB 12
Testing effectiveness (Phase 2)Study completedNCT00051974
What this trial is testing

Phase 2 Study of VELCADE Alone or VELCADE® Plus Docetaxel in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Millennium Pharmaceuticals, Inc. 155
Testing effectiveness (Phase 2)Study completedNCT04364620
What this trial is testing

AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

Who this might be right for
NSCLC Stage IV
Alethia Biotherapeutics 35
Early research (Phase 1)Looking for participantsNCT06983743
What this trial is testing

ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic Solid Tumors
Erasca, Inc. 600
Not applicableNot Yet RecruitingNCT01595074
What this trial is testing

Biomarkers in Predicting Treatment Response in Samples From Patients With Early-Stage Non-Small Cell Lung Cancer Previously Treated With Adjuvant Chemotherapy

Who this might be right for
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 950
Large-scale testing (Phase 3)Study completedNCT01040780
What this trial is testing

Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Non-small Cell Lung Cancer
Betta Pharmaceuticals Co., Ltd. 399
Early research (Phase 1)Study completedNCT03656705
What this trial is testing

CCCR-NK92 Cells Immunotherapy for Non-small Cell Lung Carcinoma

Who this might be right for
Non-small Cell Lung Cancer
Henan Medical University 2
Large-scale testing (Phase 3)Study completedNCT03922997
What this trial is testing

Investigate the Safety and Efficacy of Atezolizumab in Previously-Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hoffmann-La Roche 101
Early research (Phase 1)Study completedNCT01783197
What this trial is testing

Study of Selumetinib in Patients With Previously Treated or Untreated Advanced/Metastatic NSCLC

Who this might be right for
Non Small Cell Lung Cancer
Canadian Cancer Trials Group 39
Testing effectiveness (Phase 2)Study completedNCT02321540
What this trial is testing

A Phase I/II Study of Ibrutinib in Previously Treated Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT03472560
What this trial is testing

Avelumab in Combination With Axitinib In Non-Small Cell Lung Cancer (NSCLC) or Urothelial Cancer (Javelin Medley VEGF)

Who this might be right for
Non-Small Cell Lung CancerUrothelial Cancer
Pfizer 61
Testing effectiveness (Phase 2)Active Not RecruitingNCT04310007
What this trial is testing

Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

Who this might be right for
Metastatic Lung Non-Squamous Non-Small Cell CarcinomaRecurrent Lung Non-Squamous Non-Small Cell CarcinomaStage IV Lung Cancer AJCC v8
National Cancer Institute (NCI) 117
Testing effectiveness (Phase 2)Ended earlyNCT01526928
What this trial is testing

Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients

Who this might be right for
Locally Advanced or Metastatic Non Small Cell Lung Cancer
Clovis Oncology, Inc. 612
Next Page